Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 1063-1071

  Calingasan, Noel Y ^a   Gandy, Samuel E ^a   Baker, Harriet ^a   Sheu, Kwan Fu Rex ^a   Smith, Jonathan D ^b   Lamb, Bruce T ^c   Gearhart, John D ^c   Buxbaum, Joseph D ^b   Harper, Clive ^d   Selkoe, Dennis J ^e   Price, Donald L ^c   Sisodia, Sangram S ^c   Gibson, Gary E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PYRITHIAMINE; THIAMINE; THIOFLAVINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFERIOR COLLICULUS; KORSAKOFF PSYCHOSIS; MALE; MAMMILLARY BODY; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; ROSETTE FORMATION; THALAMUS; THIAMINE DEFICIENCY; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURITES; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

EID: 10144231437     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Heroux M, Butterworth RF: Animal models of the Wernicke-Korsakoff syndrome. Neuromethods, vol. 22: Animal Models of Neurological Disease. Edited by A Boulton, G Baker, R Butterworth. The Humana Press, 1992, pp 95-131
2. Victor M, Adams RD, Collins GH: The Wernicke-Korsakoff Syndrome. Philadelphia, FA Davis Co, 1977
3. Calingasan NY, Gandy SE, Baker H, Sheu K-FR, Kim K-S, Wisniewski HM, Gibson GE: Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res 1995, 677:50-60
4. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995, 373:523-527
5. Arendt T, Bigl V, Tennstedt A: Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakoff's disease. Acta Neuropathol 1983, 61:101-108
6. Witt ED: Neuroanatomical consequences of thiamine deficiency: a comparative analysis. Alcohol 1985, 2:201-221
7. Blass JP, Gibson GE: Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff Syndrome. N Engl J Med 1977, 297:1367-1370
8. Gibson GE, Ksiezak-Reding H, Sheu K-FR, Mykytyn V, Blass JP: Correlation of enzymatic, metabolic, and behavioral deficits in thiamine deficiency and its reversal. Neurochem Res 1984, 9:803-814
9. Butterworth RF: Cerebral thiamine-dependent enzyme changes in experimental Wernicke's encephalopathy. Metab Brain Dis 1986, 1:165-175
10. Gibson GE, Sheu K-FR, Baker AC, Carlson KC, Hard-ing B, Perrino P: Reduced activities of thiamine-dependent enzymes in brains and peripheral tissues of Alzheirner patients. Arch Neurol 1988, 45:836-840
11. Vorhees CV, Schmidt DE, Barrett RJ: Effects of pyrithiamin and oxythiamin on acetylcholine levels and utilization in rat brain. Brain Res Bull 1978, 3:493-496
12. Barclay LL, Gibson GE, Blass JP: Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J Pharmacol Exp Ther 1981, 217:537-543
13. Coyle JT, Price DL, DeLong MR: Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219:1184-1190
14. Terry RD, Katzman R: Senile dementia of the Alzheimer type. Ann Neurol 1984, 14:497-506
15. Reuler JB, Girard DE, Cooney TG: Current concepts: Wernicke's encephalopathy. N Engl J Med 1985, 313: 1035-1039
16. Langlais PJ, Savage LM: Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalon, cortex, and white matter. Behav Brain Res 1995, 68: 75-89
17. Slunt HH, Thinakaran G, Von Koch C, Lo ACY, Tanzi RE, Sisodia SS: Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J Biol Chem 1994, 269:2637-2644
18. Otsuka N, Tomonaga M, lkeda K: Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 1991, 568:335-338
19. Shigematsu K, McGeer PL: Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. Am J Pathol 1992, 140:787-794
20. Iverfeldt K, Walaas Sl, Greengard P: Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc Natl Acad Sci USA 1993, 90:4146-4150
21. Kalaria RN, Bhatti SU, Palatinsky EA, Pennington DH, Shelton ER, Chan HW, Perry G, Lust WD: Accumulation of the β-amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport 1993, 4:211-217
22. Hajimohammadreza I, Anderson VER, Cavanagh JB, Seville MP, Nolan CC, Anderton BH, Leigh PN: β-amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain after ventricular infusion of leupeptin. Brain Res 1994, 640:25-32
23. DeWardner HE, Lennox B: Cerebral beriberi (Wernicke's encephalopathy). Lancet 1947, 1:11-17
24. Burgess RC: Beriberi: epidemiology. Fed Proc 1958, 17:3-8
25. Freeman GB, Nielsen PN, Gibson GE: Effect of age on behavioral and enzymatic changes during thiamin deficiency. Neurobiol Aging 1987, 8:429-434
26. McFarland DJ: Mouse phenotype modulates the behavioral effects of acute thiamine deficiency. Physiol Behavior 1985, 35:597-601
27. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid ßpeptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:8098-8102
28. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:1977-1981
29. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Growden J, Alberts MJ, Hulette C, Grain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472
30. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD: Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet 1993, 5:22-30
31. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein Edeficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353
32. Calingasan NY, Baker H, Sheu K-FR, Gibson GE: Blood-brain abnormalities in vulnerable brain regions during thiamine deficiency. Exp Neural 1995, 134: 64-72
33. Hsu S, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
34. Guntern R, Bouras C, Hof PR, Valet PG: An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 1992, 48:8-10
35. Watanabe I: Pyrithiamine-induced acute thiamine-deficient encephalopathy in the mouse. Exp MoI Pathol 1978, 28:381-394
36. Watanabe I, Kanabe S: Early edematous lesion of pyrithiamine induced acute thiamine deficient encephalopathy in the mouse. J Neuropathol Exp Neurol 1978, 37:401-413
37. Watanabe I, Tomito T, Hung K-G, Iwasaki Y: Edematous necrosis in thiamine-deficient encephalopathy of the mouse. J Neuropathol Exp Neural 1981, 40:454-471
38. Sisodia SS, Koo EH, Hoffman PN, Perry G, Price DL: Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci 1993, 13:3136-3142
39. Thinakaran G, Sisodia SS: Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site. J Biol Chem 1994, 269:22099-22104
40. Pappolla MA, Omar RA, Kim KS, Robakis NK: lmmunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol 1992, 140:621-628
41. Smith MA, Kutty RK, Richey PL, Van SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994, 145: 42-47
42. Smith MA, Sayre LM, Monnier VM, Perry G: Radical AGEing in Alzheimer's disease. Trends Neurosci 1995, 18.172-176
43. Burke JR, Enghild JJ, Martin ME, Jou Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ: Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996, 2:347-350
44. Cullen KM, Halliday GM: Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics. Metab Brain Dis 1995, 10:81-91
45. Cullen KM, Halliday GM: Neurofibrillary tangles in chronic alcoholics. Neuropathol Appl Neurobiol 1995, 21:312-318
46. Munoz DG, Wang D: Tangle-associated neuritic clusters: a new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with β/A4. Am J Pathol 1992, 140:1167-1178
47. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R: An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 1993, 142: 871-882
48. Takemura M, Nakamura S, Akiguchi I, Ueno M, Oka N, Ishikawa S, Shimada A, Kimura J, Takeda T: β/A4 protein-like immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol 1993, 142:1887-1897
49. Wasco W, Gurubhagavatula S, Paradis MD, Romano DM, Sisodia SS, Hyman BT, Neve RL, Tanzi RE: Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid-β protein precursor. Nature Genet 1993, 5:95-100
50. Thinakaran G, Kitt CA, Roskams JI, Slunt HH, Masliah E, von Koch C, Ginsberg S, Ronnettet GV, Reed RR, Price DL, Sisodia SS: Distribution of an APP homologue, APLP2, in the olfactory system: a potential role for APLP2 in axogenesis. J Neurosci 1995, 15:6314-6326
51. Bhasin R, Van Nostrand W, Saitoh T, Donets M, Barnes E, Quitschke W, Goldgaber D: Expression of active secreted forms of human amyloid β-protein precursor by recombinant baculovirus-infected cells. Proc Natl Acad Sci USA 1991, 88:10307-10311
52. Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso PJ, Ramabhadran T, Unterbeck AJ, Greengard P: Processing of Alzheimer β/A4-amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 1990, 87:6003-6006
53. Caporaso GL, Gandy SE, Buxbaum JD, Greengard P: Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 1992, 89:2252-2256
54. Gandy SE, Bhasin R, Ramabhadran TV, Koo EH, Price DL, Goldgaber D, Greengard P: Alzheimer β/A4 amyloid precursor protein: evidence for putative amyloidogenic fragment. J Neurochem 1992, 58:383-386
55. Nordstedt C, Gandy SE, Alafuzoff I, Caporaso GL, Iverfeldt K, Grebb JA, Winblad B, Greengard P. Alzheimer β/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA 1991, 88:8910-8914
56. Suzuki T, Nairn AC, Gandy SE, Greengard P: Phosphorylation of Alzheimer amyloid precursor protein by protein kinase. Neuroscience 1992, 48:755-761
57. Haass C, Hung AY, Selkoe DJ: Processing of β-amyloid precursor protein in microglia and astrocytes favors a localization in internal vesicles. J Neurosci 1991, 11:3783-3793
58. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB: Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992, 359:322-325
59. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H. Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736